This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

10 Biotech Stocks With A History Of Beating Earning Expectations


7. Alexion Pharmaceuticals, Inc. (ALXN): Engages in the discovery, development, and commercialization of biologic therapeutic products in the United States, Europe, Latin America, Japan, and the Asia Pacific. Market cap at $19.49B, most recent closing price at $100.31.In Dec 2011: Reported EPS at 0.41 vs. estimate at 0.34 (surprise of 20.6%). In Mar 2012: Reported EPS at 0.45 vs. estimate at 0.39 (surprise of 15.4%). In Jun 2012: Reported EPS at 0.47 vs. estimate at 0.37 (surprise of 27%). In Sep 2012: Reported 0.6 vs. estimate at 0.47 (surprise of 27.7%. [Average earnings surprise at 22.68%].


8. Questcor Pharmaceuticals, Inc. (QCOR): Provides prescription drugs for central nervous system and inflammatory disorders. Market cap at $1.55B, most recent closing price at $26.47.In Dec 2011: Reported EPS at 0.47 vs. estimate at 0.42 (surprise of 11.9%). In Mar 2012: Reported EPS at 0.61 vs. estimate at 0.52 (surprise of 17.3%). In Jun 2012: Reported EPS at 0.69 vs. estimate at 0.64 (surprise of 7.8%). In Sep 2012: Reported 0.97 vs. estimate at 0.77 (surprise of 26%. [Average earnings surprise at 15.75%].


9. Charles River Laboratories International, Inc. (CRL): Provides research models and laboratory animal support expertise to help its global partners advance their research and drug development efforts. Market cap at $1.94B, most recent closing price at $39.91.In Dec 2011: Reported EPS at 0.69 vs. estimate at 0.56 (surprise of 23.2%). In Mar 2012: Reported EPS at 0.7 vs. estimate at 0.65 (surprise of 7.7%). In Jun 2012: Reported EPS at 0.75 vs. estimate at 0.66 (surprise of 13.6%). In Sep 2012: Reported 0.65 vs. estimate at 0.62 (surprise of 4.8%. [Average earnings surprise at 12.32%].


10. Illumina Inc. (ILMN): Develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. Market cap at $6.48B, most recent closing price at $52.53.In Dec 2011: Reported EPS at 0.35 vs. estimate at 0.31 (surprise of 12.9%). In Mar 2012: Reported EPS at 0.36 vs. estimate at 0.33 (surprise of 9.1%). In Jun 2012: Reported EPS at 0.4 vs. estimate at 0.37 (surprise of 8.1%). In Sep 2012: Reported 0.41 vs. estimate at 0.39 (surprise of 5.1%. [Average earnings surprise at 8.8%].



( List compiled by Rebecca Lipman)


3 of 3

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,574.57 +217.70 1.25%
S&P 500 2,034.30 +21.41 1.06%
NASDAQ 4,697.1520 +52.84 1.14%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs